References:
- Garraway, L.A., Widlund, H. R., Rubin, M.A., Getz, G.A., Berger, A.J., Ramaswamy, S., Beroukhim, R., Milner, D.A., Granter, S.R., Du, J., Lee, C., Wagner, S.N., Li, C., Golub, T.R., Rimm, D.L., Meyerson, M., Fisher, D.E., & Sellers, W.R. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature. 436: 117-122, 2005. News and Views: Nature. 436:33-35, 2005.
- Solit, D.B., Garraway, L.A., Pratilas, C.A. Sawai, A., Getz, G., Basso, A., Ye, Q., Lobo, J.M., She, Y., Osman, I., Golub, T.R., Sebolt-Leopold, J., Sellers, W.R., Rosen, N. BRAF mutation predicts sensitivity to MEK inhibition. Nature. 439:358-62, 2006.
- Garraway, L.A. and Sellers, W.R. Lineage dependency and ‘lineage survival’ oncogenes in human cancer. Nature Reviews Cancer, 2006. 593-602.
- Thomas, R.K., Baker, A.C., Debiasi, R.M., Winckler, W., Laframboise, T., Lin, W.M., Wang, M., Feng, W., Zander, T., Macconnaill, L.E., Lee, J.C., Nicoletti, R., Hatton, C., Goyette, M., Girard, L., Majmudar, K., Ziaugra, L., Wong. K.-K., Gabriel, S., Beroukhim, R., Peyton, M., Barretina, J., Dutt, A., Emery, C., Greulich, H., Shah, K., Sasaki, H., Gazdar, A., Minna, J., Armstrong, S.A., Mellinghoff, I.K., Hodi, F.S., Dranoff, G., Mischel, P.S., Cloughesy, T.F., Nelson, S.F., Liau, L.M., Mertz, K., Rubin, M.A., Moch, H., Loda, M., Catalona, W., Fletcher, J., Signoretti, S., Kaye, F., Anderson, K.C., Demetri, G.D., Dummer, R., Wagner, S., Herlyn, M., Sellers, W.R., Meyerson, M., & Garraway, L.A. High-throughput oncogene mutation profiling in human cancer. Nature Genetics. 2007;39(3):347-351.
|